Cargando…
Tailoring therapies to counter the divergent immune landscapes of breast cancer
Breast cancer remains a significant clinical concern affecting millions of women worldwide. Immunotherapy is a rapidly growing drug class that has revolutionized cancer treatment but remains marginally successful in breast cancer. The success of immunotherapy is dependent on the baseline immune resp...
Autores principales: | Attalla, Sherif, Taifour, Tarek, Muller, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992199/ https://www.ncbi.nlm.nih.gov/pubmed/36910138 http://dx.doi.org/10.3389/fcell.2023.1111796 |
Ejemplares similares
-
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo
por: Attalla, Sherif, et al.
Publicado: (2020) -
‘Omics Approaches to Explore the Breast Cancer Landscape
por: Parsons, Joseph, et al.
Publicado: (2020) -
Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Integrated Chromatin Accessibility and Transcriptome Landscapes of Doxorubicin-Resistant Breast Cancer Cells
por: Wang, Xuelong, et al.
Publicado: (2021) -
Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)